GSK3B and early-onset autosomal dominant Alzheimer disease: Interestingly, the decrease in proteins like glycogen synthase kinase 3 beta (GSK3β) or CDK5, the most relevant kinases engaged in Alzheimer’s disease pathogenesis, reduces the phosphorylation of the microtubule-binding protein tau, likely contributing to cognitive function restoration [51,52].